Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of October 26, 2026, CLDI trades at $0.63 with a market cap of $1.67M and a P/E ratio of -0.17. CLDI moved -3.87% today. Year to date, CLDI is -96.58%; over the trailing twelve months it is -97.37%. Its 52-week range spans $0.62 to $307.20. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest CLDI news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.63 |
| Market Cap | $1.67M |
| P/E Ratio | -0.17 |
| EPS | $-5.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $307.20 |
| 52-Week Low | $0.62 |
| Volume | 41.17K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-20.06M |
| Gross Margin | 0.00% |
CLDI analyst coverage data. Average price target: $0.00.